Amwell names Mark Hirschhorn CFO, effective Oct. 21

Amwell announced Mark Hirschhorn will become Amwell Chief Financial Officer, CFO, effective Oct. 21, succeeding Robert “Bob” Shepardson, who has been in the role since 2021. Hirschhorn will oversee Amwell’s financial operations, enterprisewide optimization and capital allocation activities, and will play a meaningful leadership role in guiding the company’s strategy to support its long-term growth objectives and enhance shareholder value…”Mark’s experience blends keen financial acumen and seasoned leadership, encompassing corporate finance, operations, strategy, capital allocation and M&A,” said Ido Schoenberg, M.D., chairman and CEO of Amwell. “This change represents an evolution for our company as we move beyond a period of intense R&D investment to an operational focus aimed at achieving greater efficiencies, optimizing cash flow and delivering profitable growth while maintaining our dedication to enabling our clients’ aspirations. Mark makes a great addition to our executive team and is dedicated to leading the company for the benefit of all stakeholders – clients, shareholders and team members.”